About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
About Us
Overview
Company Milestones
Our Facilities
Products
Medical Information
Contact Us
2016 – Zydus began supplying product in the US market from its SEZ facility
Post navigation
Previous:
2016 – Zydus and Takeda entered into partnership to address emerging infection diseases
Next:
2016 – Zydus received approval from the USFDA to initiate Phase II clinical trials of saroglitazar in patients with Non-Alcoholic Steatohepatitis (NASH) of the liver in the US